Methemoglobinemia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Template) |
|||
Line 8: | Line 8: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention consists of avoiding oxidizing agents in people with diagnosed G6PD deficiency or known congenital deficiency of the reductase enzyme. | |||
==References== | ==References== |
Revision as of 00:37, 30 April 2018
Methemoglobinemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Methemoglobinemia secondary prevention On the Web |
American Roentgen Ray Society Images of Methemoglobinemia secondary prevention |
Risk calculators and risk factors for Methemoglobinemia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Secondary Prevention
Secondary prevention consists of avoiding oxidizing agents in people with diagnosed G6PD deficiency or known congenital deficiency of the reductase enzyme.